To decipher the potential mechanisms of the drug combinations in COVID-19, enrichment analysis was performed to determine the impact of the targets on the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways related to TNF-α, IL-1β, and BLT1, which are inflammatory mediators associated with inflammation in the upper respiratory tract. The gene discussed is LTB4R; the disease is COVID-19.